Published in Head Neck on May 01, 2002
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol (2009) 2.15
Chemoselection as a strategy for organ preservation in patients with T4 laryngeal squamous cell carcinoma with cartilage invasion. Laryngoscope (2009) 1.17
Staging of laryngeal and hypopharyngeal cancer: value of imaging studies. Eur Radiol (2006) 1.02
MicroRNAs in laryngeal cancer: implications for diagnosis, prognosis and therapy. Am J Transl Res (2016) 0.89
Results of transoral laser microsurgery for supraglottic carcinoma in 277 patients. Eur Arch Otorhinolaryngol (2013) 0.89
Causes of death of patients with laryngeal cancer. Eur Arch Otorhinolaryngol (2013) 0.85
Organ preservation in T4a laryngeal cancer: is transoral laser microsurgery an option? Eur Arch Otorhinolaryngol (2013) 0.81
Systematic review and meta-analysis of the use of tranexamic acid in tonsillectomy. Eur Arch Otorhinolaryngol (2012) 0.81
Prediction of concurrent chemoradiotherapy outcome in advanced oropharyngeal cancer. Int J Oncol (2014) 0.81
Supraglottic laryngectomy: analysis of 267 cases. Eur Arch Otorhinolaryngol (2007) 0.80
Extended and standard supraglottic laryngectomies: a review of 110 patients. Eur Arch Otorhinolaryngol (2005) 0.78
Factors predictive of outcome following primary total laryngectomy for advanced squamous cell carcinoma. Eur Arch Otorhinolaryngol (2013) 0.76
Functional outcomes of supraglottic squamous cell carcinoma treated by transoral laser microsurgery compared with horizontal supraglottic laryngectomy in patients younger and older than 65 years. Acta Otorhinolaryngol Ital (2016) 0.75
Glottic and supraglottic pT3 squamous cell carcinoma: outcomes with transoral laser microsurgery. Eur Arch Otorhinolaryngol (2015) 0.75
Functional organ preservation in laryngeal and hypopharyngeal cancer. GMS Curr Top Otorhinolaryngol Head Neck Surg (2012) 0.75
Salvage Transoral Laser Microsurgery for Radiorecurrent Laryngeal Cancer: Indications, Limits, and Outcomes. Curr Otorhinolaryngol Rep (2017) 0.75
When is definitive radiotherapy the preferred treatment for head and neck squamous cell carcinoma? Eur Arch Otorhinolaryngol (2015) 0.75
When is radiation therapy in head and neck squamous cell carcinoma not indicated? Eur Arch Otorhinolaryngol (2013) 0.75
American Society of Clinical Oncology clinical practice guideline for the use of larynx-preservation strategies in the treatment of laryngeal cancer. J Clin Oncol (2006) 2.68
Proton therapy for prostate cancer. Oncology (Williston Park) (2011) 2.11
Radiotherapy for pleomorphic adenoma. Am J Otolaryngol (2012) 2.04
Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 1.97
Contemporary management of lymph node metastases from an unknown primary to the neck: I. A review of diagnostic approaches. Head Neck (2011) 1.97
Management of T1-T2 glottic carcinomas. Cancer (2004) 1.87
Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer (2002) 1.76
Ototoxicity after radiotherapy for head and neck tumors. Int J Radiat Oncol Biol Phys (2007) 1.62
Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck (2004) 1.59
Head and neck squamous cell carcinoma from an unknown primary site. Am J Otolaryngol (2010) 1.58
Head and neck mucosal melanoma. Am J Clin Oncol (2005) 1.53
Lymph nodes of patients with regional metastases from head and neck squamous cell carcinoma as a predictor of pathologic outcome: size changes at CT before and after radiation therapy. AJNR Am J Neuroradiol (2002) 1.51
Radiation therapy and hearing loss. Int J Radiat Oncol Biol Phys (2010) 1.46
Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck (2002) 1.45
Early outcomes from three prospective trials of image-guided proton therapy for prostate cancer. Int J Radiat Oncol Biol Phys (2010) 1.44
Linear accelerator surgery for meningiomas. J Neurosurg (2005) 1.43
Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol (2006) 1.42
Papillary thyroid carcinoma: prognostic factors and the role of radioiodine and external radiotherapy. Int J Radiat Oncol Biol Phys (2002) 1.35
Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope (2009) 1.33
T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.32
Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck (2004) 1.30
Skull base chordoma. Head Neck (2005) 1.28
Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol (2006) 1.27
Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer (2005) 1.26
Elective and therapeutic selective neck dissection. Oral Oncol (2005) 1.26
Head and neck paragangliomas. Head Neck (2010) 1.24
Implications for clinical staging of metastatic cutaneous squamous carcinoma of the head and neck based on a multicenter study of treatment outcomes. Cancer (2006) 1.22
External beam radiotherapy for differentiated thyroid cancer. Am J Otolaryngol (2005) 1.21
Skin carcinoma of the head and neck with perineural invasion. Am J Otolaryngol (2011) 1.20
Mucosal melanoma of the head and neck. Am J Clin Oncol (2008) 1.19
Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med (2002) 1.17
Skin cancer of the head and neck with perineural invasion. Am J Clin Oncol (2007) 1.17
Tumor volume predicts outcome for advanced head and neck cancer treated with targeted chemoradiotherapy. Laryngoscope (2002) 1.17
Radiotherapy in the treatment of dermatofibrosarcoma protuberans. Am J Clin Oncol (2005) 1.15
Neck dissection: then and now. Auris Nasus Larynx (2006) 1.14
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck (2003) 1.13
Contemporary management of lymph node metastases from an unknown primary to the neck: II. a review of therapeutic options. Head Neck (2011) 1.13
Jugular and vagal paragangliomas: Systematic study of management with surgery and radiotherapy. Head Neck (2012) 1.13
Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope (2009) 1.12
Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study. Laryngoscope (2009) 1.11
Ewing tumors of the head and neck. Am J Clin Oncol (2010) 1.11
Radiation therapy for angiosarcoma. Head Neck (2003) 1.11
Primary and central hypothyroidism after radiotherapy for head-and-neck tumors. Int J Radiat Oncol Biol Phys (2007) 1.11
Intra-arterial chemotherapy for head and neck cancer: is there a verdict? Cancer (2010) 1.10
The role of neck dissection in the setting of chemoradiation therapy for head and neck squamous cell carcinoma with advanced neck disease. Oral Oncol (2011) 1.09
Retropharyngeal lymph node metastases in head and neck malignancies. Head Neck (2010) 1.09
Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope (2008) 1.09
Physical activity correlates and barriers in head and neck cancer patients. Support Care Cancer (2007) 1.08
Mandibular osteoradionecrosis. J Clin Oncol (2004) 1.07
Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol (2006) 1.07
Neck dissection: past, present and future? J Laryngol Otol (2005) 1.07
Current management of mucosal melanoma of the head and neck. J Surg Oncol (2003) 1.07
Preventing radiation retinopathy with hyperfractionation. Int J Radiat Oncol Biol Phys (2005) 1.06
Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck (2003) 1.05
Post-RT CT results as a predictive model for the necessity of planned post-RT neck dissection in patients with cervical metastatic disease from squamous cell carcinoma. Int J Radiat Oncol Biol Phys (2002) 1.04
Erectile function, incontinence, and other quality of life outcomes following proton therapy for prostate cancer in men 60 years old and younger. Cancer (2012) 1.04
Adenoid cystic carcinoma of the head and neck. Am J Otolaryngol (2012) 1.04
Proposal for a rational classification of neck dissections. Head Neck (2010) 1.04
A radiation oncologist's guide to contouring the hippocampus. Am J Clin Oncol (2009) 1.04
Management of sinonasal undifferentiated carcinoma. Head Neck (2008) 1.04
Radiotherapy in the management of giant cell tumor of bone. Am J Clin Oncol (2013) 1.04
Recurrent and second primary squamous cell carcinoma of the head and neck: when and how to reirradiate. Head Neck (2014) 1.02
Classification of neck dissections: an evolving system. Auris Nasus Larynx (2008) 1.02
Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope (2010) 1.02
Carcinoma of the skin with perineural invasion. Head Neck (2003) 1.02
Swallowing and speech ability after treatment for head and neck cancer with targeted intraarterial versus intravenous chemoradiation. Head Neck (2002) 1.02
Second tumors in pediatric patients treated with radiotherapy to the central nervous system. Am J Clin Oncol (2012) 1.01
Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord. Int J Radiat Oncol Biol Phys (2009) 1.01